en
svPress releases
Press release 2022-05-06
Xspray Pharma – Capital Markets Day Invitation
Regulatory press release 2022-05-06
An eventful quarter sets the agenda for an intense 2022
Press release 2022-04-19
The Nomination Committee’s proposal for the Board of Directors of Xspray Pharma AB
Regulatory press release 2022-04-19
Notice of annual general meeting of Xspray Pharma AB (publ)
Regulatory press release 2022-03-25
Xspray Pharma publishes its annual report for 2021
Press release 2022-02-24
Update on recent developments regarding Dasynoc
Regulatory press release 2022-02-18
Xspray Pharma publishes Q4 Year-End report 2021
Regulatory press release 2022-02-07
Xspray Pharma appoints Global Head of Marketing and Sales
Regulatory press release 2022-01-13
FDA allows review of application for market approval for Xspray Pharma’s Dasynoc™
Regulatory press release 2021-11-30